+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 6032438
The global breast cancer brachytherapy market size is estimated to reach USD 1.3 billion by 2030, expanding at a CAGR of 6.9% from 2025 to 2030. The increasing prevalence of breast cancer is expected to accelerate market growth. For instance, the Breastcancer.org reported that as of January 2020, there were more than 3.5 million women suffering from breast cancer in the U.S.

In addition, the rising adoption of brachytherapy by academic medical centers, oncology centers, and hospitals is expected to boost the market growth. For instance, in October 2018, Navicent Health adopted the Xoft Axxent Electronic Brachytherapy (eBx) System developed by iCAD, Inc. for the treatment of breast cancer in Georgia. Furthermore, in October 2018, SUNY Upstate Medical University also adopted the Xoft Axxent Electronic Brachytherapy (eBx) System to provide treatment for early-stage breast cancer.

Moreover, government hospitals in developing countries are installing advanced systems to provide better quality treatment for their patients. For instance, in August 2018, Eckert and Ziegler BEBIG delivered and installed SagiNova HDR afterloader at BP Koirala Memorial Cancer Hospital of Nepal. SagiNova is suitable for interstitial breast implants. Hence, the use of such brachytherapy systems by hospitals is expected to fuel market growth.

Market players entering into strategic initiatives such as collaborations and partnerships are anticipated to propel the demand over the next few years. For instance, in July 2018, RaySearch partnered with Eckert and Ziegler BEBIG to integrate SagiNova with the RayCare oncology information system and RayStation treatment planning system to improve treatment outcomes during brachytherapy.

An increase in funding initiatives for HDR units in medical centers by organizations is estimated to drive the market. For instance, in April 2019, OSJ Charities Trust Fund collaborated with the National Federation of Italian Canadians to donate SagiNova for Santo Spirito Hospital as an alternative to external beam radiation therapy for a targeted approach and shorter treatment time.

Favorable reimbursement policies for oncologists, surgeons, and hospitals are expected to fuel market growth. For instance, HDR brachytherapy offers USD 11,000 as Medicare reimbursement for five days treatment period according to the coding issued by Centers for Medicare and Medicaid Services (CMS).

Breast Cancer Brachytherapy Market Report Highlights

  • HDR brachytherapy dominated the market in 2024 and is also projected to be the fastest-growing technology segment over the forecast period
  • Factors such as rapid delivery of radiation, accuracy, and precise tumor-specific dose delivery in a shorter period of time are expected to drive the segment
  • North America has dominated the market in 2024 owing to the presence of key players and increasing adoption of the therapy by oncology centers and hospitals
  • In Asia Pacific, the market is estimated to grow fast over the forecast period due to high unmet needs and growth opportunities for investors and companies to expand their presence in the region.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Product
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Breast Cancer Brachytherapy Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Breast Cancer Brachytherapy Market: Technology Business Analysis
4.1. Technology Market Share, 2024 & 2030
4.2. Technology Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
4.4. High Dose Rate (HDR)
4.4.1. High Dose Rate (HDR) Market, 2018 - 2030 (USD Million)
4.5. Low Dose Rate (LDR)
4.5.1. Low Dose Rate (LDR) Market, 2018 - 2030 (USD Million)
Chapter 5. Breast Cancer Brachytherapy Market: Product Business Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Applicators and Afterloaders
5.4.1. Applicators and Afterloaders Market, 2018 - 2030 (USD Million)
5.5. Electronic Brachytherapy
5.5.1. Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Breast Cancer Brachytherapy Market: Regional Estimates & Trend Analysis by Technology and Product
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Eckert & Ziegler BEBIG
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Elekta
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Varian Medical Systems, Inc.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Hologic, Inc.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Merit Medical Systems
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. BD
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global breast cancer brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 4 Global breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 5 Global breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 6 North America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
Table 7 North America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 8 North America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 10 U.S. breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 11 Canada breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 12 Canada breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 14 Mexico breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 15 Europe breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
Table 16 Europe breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 17 Europe breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 18 UK breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 19 UK breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 20 Germany breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 21 Germany breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 22 France breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 23 France breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 24 Italy breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 25 Italy breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 26 Spain breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 27 Spain breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 28 Norway breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 29 Norway breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 30 Denmark breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 31 Denmark breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 32 Sweden breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 33 Sweden breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 34 Asia Pacific breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 36 Asia Pacific breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 37 Japan breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 38 Japan breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 39 China breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 40 China breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 41 India breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 42 India breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 43 Australia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 44 Australia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 45 South Korea breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 46 South Korea breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 47 Thailand breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 48 Thailand breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 49 Latin America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 51 Latin America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 52 Brazil breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 53 Brazil breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 54 Argentina breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 55 Argentina breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 59 South Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 60 South Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 63 UAE breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 64 UAE breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 65 Kuwait breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
Table 66 Kuwait breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Breast cancer brachytherapy market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Technology and product outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Breast cancer brachytherapy market dynamics
Fig. 12 Breast cancer brachytherapy market: Porter’s five forces analysis
Fig. 13 Breast cancer brachytherapy market: PESTLE analysis
Fig. 14 Breast cancer brachytherapy market: Technology segment dashboard
Fig. 15 Breast cancer brachytherapy market: Technology market share analysis, 2024 & 2030
Fig. 16 High dose rate (HDR) market, 2018 - 2030 (USD Million)
Fig. 17 Low dose rate (LDR) market, 2018 - 2030 (USD Million)
Fig. 18 Breast cancer brachytherapy market: Product segment dashboard
Fig. 19 Breast cancer brachytherapy market: Product market share analysis, 2024 & 2030
Fig. 20 Applicators and afterloaders market, 2018 - 2030 (USD Million)
Fig. 21 Electronic brachytherapy market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Breast cancer brachytherapy market revenue, by region
Fig. 24 Regional marketplace: Key takeaways
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 North America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 27 U.S. country dynamics
Fig. 28 U.S. breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 29 Canada country dynamics
Fig. 30 Canada breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 31 Mexico country dynamics
Fig. 32 Mexico breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 33 Europe breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 34 UK country dynamics
Fig. 35 UK breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 36 Germany country dynamics
Fig. 37 Germany breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 38 France country dynamics
Fig. 39 France breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 40 Italy country dynamics
Fig. 41 Italy breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 42 Spain country dynamics
Fig. 43 Spain breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 44 Norway country dynamics
Fig. 45 Norway breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 46 Sweden country dynamics
Fig. 47 Sweden breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 48 Denmark country dynamics
Fig. 49 Denmark breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 51 Japan country dynamics
Fig. 52 Japan breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 53 China country dynamics
Fig. 54 China breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 55 India country dynamics
Fig. 56 India breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 57 Australia country dynamics
Fig. 58 Australia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 59 South Korea country dynamics
Fig. 60 South Korea breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 61 Thailand country dynamics
Fig. 62 Thailand breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 63 Latin America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 64 Brazil country dynamics
Fig. 65 Brazil breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 66 Argentina country dynamics
Fig. 67 Argentina breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 68 MEA breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 69 South Africa country dynamics
Fig. 70 South Africa breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia country dynamics
Fig. 72 Saudi Arabia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 73 UAE country dynamics
Fig. 74 UAE breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 75 Kuwait country dynamics
Fig. 76 Kuwait breast cancer brachytherapy market, 2018 - 2030 (USD Million)
Fig. 77 Company categorization
Fig. 78 Company market position analysis
Fig. 79 Strategic framework

Companies Mentioned

  • Eckert & Ziegler BEBIG
  • Elekta
  • Varian Medical Systems, Inc.
  • Hologic, Inc.
  • Merit Medical Systems
  • BD

Methodology

Loading
LOADING...

Table Information